
Biokinetica S.A.
Research and experimental development in natural sciences and engineering
Overview
Biokinetica is an early-phase clinical research center for volunteers and a partner for clients. It conducts high-quality trials with rapid recruitment, specialist supervision and uncompromising safety, supporting the development of new therapies.
Financials
Revenue history (in k)
Filing timeliness
6 of 6 financial statements were filed late (the longest delay 1014 days for 2020). 1 of 6 audited by a statutory auditor.
- 202511/08/2026
- 202408/05/2026
- 202325/07/2024
- 202225/07/2024
- 202125/07/2024
- 202025/07/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical trials
- Early-phase clinical trials
- Volunteer recruitment
Websites
- biokinetica.comBiokineticaNginx
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| PRZYJAZNE BADANIA KLINICZNE | Z.483463 | 41, 42, 44 | Protected | Mar 13, 2028 |
| Mark | Protected until | |
|---|---|---|
| PRZYJAZNE BADANIA KLINICZNE | Mar 13, 2028 |
Authorized Representatives
Manner of representation
Each member of the management board acting independently is authorised to submit declarations on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2015-10-29.
93 1050 1012 1000 0090 8054 4902
62 1050 1012 1000 0090 8104 2682
86 1050 1012 1000 0090 3068 0335
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 3,860PLN 3,860 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $953$953 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $522$522 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $962$962 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kapadi sp. z o.o. | $7,248,714.39 | kapadi.com | ||
| Penta Hospitals Badania Kliniczne sp. z o.o. | $4,302,611.75 | psychodelikibadania.pl | ||
| Brillance sp. z o.o. | $3,327,685.13 | brillance.pl | ||
| Clinchoice sp. z o.o. | $2,847,034.16 | clinchoice.com | ||
| Aslab Science P.S.A. | $1,504,132.17 | aslabsci.com | ||
| Associated Medical Clinical Science Services sp. z o.o. | $1,449,035.10 | associated-medical.com.pl | ||
| Target Point sp. z o.o. | $1,420,831.09 | targetpoint.pl | ||
| Bioresearch Group sp. z o.o. | $776,186.19 | bioresearch.pl | ||
| Scientia Cro sp. z o.o. | $607,622.19 | scientiacro.com | ||
| CTI Clinical Trial and Consulting Services Poland sp. z o.o. | $527,145.56 | ctifacts.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-30 | Switch to PKD 2025 (4 PKD 2007 codes → 6 PKD 2025 codes) | |
| 2021-03-12 | Address change (Ul. Augustyna Locciego 5/2, 02-928, Warszawa → Ul. Nadwiślańska 37, 05-410, Józefów) | |
| 2019-02-15 | PKD change (Added: 49.39.Z) | |
| 2018-12-19 | Address change (Ul. Bohdana Dobrzańskiego 3, 20-262, Lublin → Ul. Augustyna Locciego 5/2, 02-928, Warszawa) | |
| 2017-12-14 | PKD change (Removed: 5 codes; Added: 3 codes) |
FAQ
Last updated: 2026-08-11